Pharmacist check-ins may cut medication errors in cancer outpatients

NCT ID NCT07550478

Not yet recruiting Disease control Sponsor: Badr University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a pharmacist-led program — including medication review, counseling, and follow-up — can help adult cancer outpatients take their medications correctly and avoid errors. One hundred participants will be split into two groups: one receives standard care plus pharmacist support, the other gets standard care alone. The goal is to see if the pharmacist's help improves medication adherence and reduces mistakes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pharmacist-led medication reconciliation, counseling, and follow-up
What this could lead to: If successful, this could show that adding a pharmacist to the care team helps cancer patients manage their complex medications more safely and avoid hospital visits.
What could go wrong: This is a small, early-stage study (100 people) that measures short-term outcomes. Results may not apply to all cancer patients or settings, and the intervention may not significantly change adherence or error rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.